Semaglutide Pregnancy What Women Need To Know

If you're taking semaglutide or thinking about starting treatment, pregnancy planning is something you need to discuss with your provider. Semaglutide pregnancy safety is a topic that comes up frequently, and for good reason. If you're actively trying to conceive, might become pregnant, or want to understand the risks, this guide covers what the research says and what steps to take.

Key Takeaways: - Should You Stop Semaglutide Before Getting Pregnant - Can Semaglutide Actually Improve Fertility - Understand what about breastfeeding while on semaglutide - Planning Your Timeline: A Practical Approach

The short answer is that semaglutide should be stopped before pregnancy. But there's more nuance to this than a simple yes or no. Let's walk through the details.

Should You Stop Semaglutide Before Getting Pregnant?

Yes. Current medical guidance recommends stopping semaglutide at least two months before you plan to conceive. Some providers recommend a longer washout period of two to three months to be safe.

Here is why. Animal studies have shown potential risks to fetal development when GLP-1 receptor agonists were used during pregnancy. These studies involved doses much higher than what humans take, but because there are no large-scale human pregnancy studies, the precautionary principle applies. Semaglutide hasn't been assigned a standard FDA pregnancy category under the current labeling system, but prescribing information clearly advises against use during pregnancy.

Semaglutide has a long half-life of about seven days. That means it stays in your system for several weeks after your last injection. The two-month washout period ensures the medication is fully cleared from your body before conception.

If you discover you're pregnant while taking semaglutide, contact your provider immediately. They will advise you to stop the medication right away. An unplanned exposure doesn't automatically mean harm, but your provider will want to monitor your pregnancy more closely.

"GLP-1 receptor agonists represent the most significant advance in obesity pharmacotherapy in decades. For the first time, we have medications that produce weight loss approaching what was previously only achievable through bariatric surgery.") Dr. Robert Kushner, MD, Northwestern University, speaking at ObesityWeek 2023

This guidance applies to all GLP-1 medications, not just semaglutide. If you're considering other options, learn about the and discuss family planning with your provider.

Free Download: Semaglutide Titration Tracker Track your dosing schedule, plan your washout timeline, and log key dates with our printable titration tracker. Get yours free (we'll email it to you instantly. [Download Now]

Can Semaglutide Actually Improve Fertility?

This is where the conversation gets interesting. While semaglutide itself isn't a fertility treatment, the weight loss it produces can significantly improve reproductive health. For a complete cost breakdown, see our compare semaglutide prices.

Patient Perspective: "I was skeptical about another weight loss medication after trying so many things. By week 8 on semaglutide, I noticed I wasn't thinking about food constantly for the first time in years. The nausea was real the first two weeks, but manageable with smaller meals.") Sarah M., 47, FormBlends patient (name changed for privacy)

Obesity is one of the leading modifiable risk factors for infertility. Excess weight can disrupt hormonal balance, interfere with ovulation, and reduce the effectiveness of fertility treatments. Conditions like polycystic ovary syndrome (PCOS), which affects up to 12% of women of reproductive age, are closely linked to insulin resistance and weight.

Clinical data indicate that even a 5-10% reduction in body weight can restore ovulation in some women with PCOS. Semaglutide helps many patients achieve well beyond that level of weight loss. Clinical trials showed an average weight reduction of about 15% over 68 weeks.

Weight loss before pregnancy also reduces the risk of gestational diabetes, preeclampsia, and cesarean delivery. It can improve egg quality and create a healthier hormonal environment for conception.

This is one reason some providers prescribe semaglutide to women who are planning to conceive in the future but aren't currently trying. The goal is to improve weight and metabolic health first, then stop the medication and begin the conception process.

If you're interested in using semaglutide as part of a pre-conception health plan, who can build a timeline that accounts for your fertility goals.

What About Breastfeeding While on Semaglutide?

Semaglutide isn't recommended during breastfeeding. There's limited data on whether the medication passes into breast milk or what effect it could have on a nursing infant.

Animal studies showed that semaglutide was present in the milk of lactating rats. While animal data doesn't always translate directly to humans, the lack of human studies means the safest approach is to avoid semaglutide while breastfeeding.

If you want to resume semaglutide after giving birth, talk to your provider about timing. Many women wait until they have finished breastfeeding before restarting GLP-1 treatment. Your provider can help you develop a postpartum plan that supports both your health goals and your baby's nutrition needs.

During this period, focusing on nutrition and exercise can help maintain the progress you made before pregnancy. Our offers practical ideas for nutrient-dense eating that works well postpartum.

Planning Your Timeline: A Practical Approach

If you want to use semaglutide for weight loss and also plan to get pregnant, here is a general framework to discuss with your provider.

Phase 1: Active treatment. Take semaglutide as prescribed. Focus on reaching a healthy weight. Build sustainable nutrition and exercise habits that will carry you through pregnancy and beyond. Use the to track your progress and build a data history for your provider.

Phase 2: Transition and washout. At least two months before you want to start trying to conceive, work with your provider to taper off semaglutide. During this period, your appetite regulation may shift. Having strong habits in place from Phase 1 helps you maintain your weight without medication.

Phase 3: Conception and pregnancy. Once semaglutide is fully cleared from your system, you can begin trying to conceive. Continue the healthy eating and exercise habits you built during treatment.

Phase 4: Postpartum. After delivery and breastfeeding, if applicable, you can discuss restarting semaglutide with your provider if needed. Some women find that the habits they built during treatment are enough to maintain their weight without medication.

Every woman's timeline is different. Your age, health history, fertility status, and weight goals all factor into the plan. A provider who understands both GLP-1 therapy and reproductive health can help you create a personalized approach.

Frequently Asked Questions

How long before getting pregnant should I stop semaglutide?

The general recommendation is at least two months before you plan to conceive. This allows the medication to fully clear from your system. Some providers suggest a longer washout period of two to three months. Discuss your specific timeline with your healthcare provider.

Can semaglutide cause birth defects?

There are no large-scale human studies on semaglutide and birth defects. Animal studies at high doses showed potential risks to fetal development. Because of this uncertainty, semaglutide isn't recommended during pregnancy. If you become pregnant while taking it, contact your provider immediately.

Will I gain weight back after stopping semaglutide to get pregnant?

Some weight regain is possible, especially as your appetite regulation changes without the medication. But if you have built strong nutrition and exercise habits during treatment, you can minimize regain. Working with your provider on a tapering and maintenance plan helps ease this transition.

Does semaglutide affect birth control effectiveness?

Semaglutide can slow gastric emptying, which may affect the absorption of oral medications, including birth control pills. If you rely on oral contraception, talk to your provider about whether you should use a backup method or switch to a non-oral form of birth control during treatment.

Can men taking semaglutide affect pregnancy?

Current research doesn't suggest that semaglutide use in men affects sperm quality or pregnancy outcomes. But research in this area is limited. If you and your partner are planning to conceive, both of you should discuss your medications with your respective providers.

Start your experience Today

Every transformation starts with a single step. Talk to a licensed FormBlends provider about whether this approach is right for you, consultations are free and confidential.

Sources &. References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
5. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
6. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
7. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
8. Nauck MA, Meier JJ. Management of endocrine disease: Are all GLP-1 agonists equal in the treatment of type 2 diabetes? Eur J Endocrinol. 2019;181(6):R211-R234. Doi:10.1530/EJE-19-0566
9. Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
10. Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816

Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.

Last updated: 2026-03-24